 Antigens, CD
"Antigens, CD" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation.
| Descriptor ID |
D015703
|
| MeSH Number(s) |
D23.050.301.264.035 D23.101.100.110
|
| Concept/Terms |
Antigens, CD- Antigens, CD
- CD Antigens
- Cluster of Differentiation Markers
- Cluster of Differentiation Antigens
|
Below are MeSH descriptors whose meaning is more general than "Antigens, CD".
Below are MeSH descriptors whose meaning is more specific than "Antigens, CD".
This graph shows the total number of publications written about "Antigens, CD" by people in this website by year, and whether "Antigens, CD" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 4 | 2 | 6 | | 1996 | 4 | 3 | 7 | | 1997 | 4 | 6 | 10 | | 1998 | 3 | 10 | 13 | | 1999 | 5 | 6 | 11 | | 2000 | 7 | 7 | 14 | | 2001 | 9 | 13 | 22 | | 2002 | 7 | 15 | 22 | | 2003 | 5 | 8 | 13 | | 2004 | 3 | 7 | 10 | | 2005 | 3 | 7 | 10 | | 2006 | 0 | 14 | 14 | | 2007 | 7 | 9 | 16 | | 2008 | 7 | 13 | 20 | | 2009 | 8 | 9 | 17 | | 2010 | 6 | 8 | 14 | | 2011 | 4 | 4 | 8 | | 2012 | 2 | 2 | 4 | | 2013 | 4 | 9 | 13 | | 2014 | 4 | 12 | 16 | | 2015 | 3 | 9 | 12 | | 2016 | 5 | 7 | 12 | | 2017 | 3 | 8 | 11 | | 2018 | 5 | 3 | 8 | | 2019 | 5 | 4 | 9 | | 2020 | 5 | 8 | 13 | | 2021 | 5 | 4 | 9 | | 2022 | 1 | 1 | 2 | | 2024 | 1 | 2 | 3 | | 2025 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Antigens, CD" by people in Profiles.
-
Elder AM, Fairchild HR, Kines KT, Cozzens LM, Becks AR, Slansky JE, Anderson SM, Lyons TR. Semaphorin7A and PD-L1 cooperatively drive immunosuppression during mammary involution and breast cancer. Cell Rep. 2025 May 27; 44(5):115676.
-
Day D, Ganju V, Chung K, Si L, Mao L, Aghmesheh M, Hoyer R, Brewin K, Zeng S, Zhang M, Lu Q, Jiang C, Ren F, Zhu Y, Guo J. First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors. Br J Cancer. 2025 Jun; 132(10):905-912.
-
Kotwal A, Simpson R, Whiteman N, Swanson B, Yuil-Valdes A, Fitch M, Nguyen J, Elhag S, Shats O, Goldner W, Bennett R. Relaxin-2 is a novel biomarker for differentiated thyroid carcinoma in humans. Biochem Pharmacol. 2024 07; 225:116323.
-
Zhang X, Heo GS, Li A, Lahad D, Detering L, Tao J, Gao X, Zhang X, Luehmann H, Sultan D, Lou L, Venkatesan R, Li R, Zheng J, Amrute J, Lin CY, Kopecky BJ, Gropler RJ, Bredemeyer A, Lavine K, Liu Y. Development of a CD163-Targeted PET Radiotracer That Images Resident Macrophages in Atherosclerosis. J Nucl Med. 2024 May 01; 65(5):775-780.
-
Yee EJ, Vigil I, Sun Y, Torphy RJ, Schulick RD, Zhu Y. Group XIV C-type lectins: emerging targets in tumor angiogenesis. Angiogenesis. 2024 May; 27(2):173-192.
-
Durda P, Raffield LM, Lange EM, Olson NC, Jenny NS, Cushman M, Deichgraeber P, Grarup N, Jonsson A, Hansen T, Mychaleckyj JC, Psaty BM, Reiner AP, Tracy RP, Lange LA. Circulating Soluble CD163, Associations With Cardiovascular Outcomes and Mortality, and Identification of Genetic Variants in Older Individuals: The Cardiovascular Health Study. J Am Heart Assoc. 2022 11; 11(21):e024374.
-
Murphy WA, Lin N, Damask A, Schwartz GG, Steg PG, Szarek M, Banerjee P, Fazio S, Manvelian G, Pordy R, Shuldiner AR, Paulding C. Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial. Circ Genom Precis Med. 2022 06; 15(3):e003503.
-
Yomogida K, Bigley TM, Trsan T, Gilfillan S, Cella M, Yokoyama WM, Egawa T, Colonna M. Hobit confers tissue-dependent programs to type 1 innate lymphoid cells. Proc Natl Acad Sci U S A. 2021 12 14; 118(50).
-
Rosenbaum SR, Tiago M, Caksa S, Capparelli C, Purwin TJ, Kumar G, Glasheen M, Pomante D, Kotas D, Chervoneva I, Aplin AE. SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects. Cell Rep. 2021 12 07; 37(10):110085.
-
Challen GA, Pietras EM, Wallscheid NC, Signer RAJ. Simplified murine multipotent progenitor isolation scheme: Establishing a consensus approach for multipotent progenitor identification. Exp Hematol. 2021 12; 104:55-63.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|